Trial Designed to Test Camsirubicin Against Doxorubicin as First-Line Therapy
Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, announces a new Solid State Chemistry service.
Spherix's investment portfolio into emerging biotech stocks has resulted in substantial gains, turning a roughly $860,000 investment into a position worth more than $11 million at current share price levels, and marking a Price to Book ratio of less than 100%. The recently announced asset-purchase agreement of CBM BioPharma extends pipeline promise.
New AI Platform Accelerates Scientific Research and Drug Discovery, includes over 300 Million Product Listings from 50,000 Vendors
Florence today announced its membership in the Avoca Quality Consortium® (AQC) to drive technology adoption and standardization in order to reduce drug costs and development time.
Lotus Clinical Research Announces the Addition of Lee Simon, MD as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD, JD as Medical Imaging and Research Advisor
Global clinical genomics market is expected to reach USD 879.0 million by 2023, at a CAGR of 17.1% during the forecast period of 2018 to 2023: Exclusive research by Meticulous Research®
Jury finds punitive damages warranted against Boehringer Ingelheim Pharmaceuticals, Inc.
Neil Singla, Chief Executive Officer of Lotus Clinical Research, Chaired the fourth annual American Pain Society Conference on Analgesic Trials (APS-CAT)